Epsilon Healthcare Receives maiden order under Valens partnership
- Epsilon Healthcare (EPN) receives the first order under its strategic partnership with The Valens Company
- The first order, totalling $540,000, is for white-labelled cannabis products and will be sold throughout Australia and New Zealand
- Epsilon expects the complete the delivery of the first two pallets in the coming week with additional deliveries expected early next year
- In early September, both companies entered a long-term partnership that allows Valens access to Epsilon’s GMP Manufacturing Facility in Queensland
- Shares in Epsilon are down 6.67 per cent on the market and are trading at 14 cents at 1:03 pm AEST
